Evidence map›Paper›PMID 30641976›Full record

ArticleDiagnostics (Basel, Switzerland)2019

Defining System Requirements for Simplified Blood Culture to Enable Widespread Use in Resource-Limited Settings.

Peter J Dailey, Jennifer Osborn, Elizabeth A Ashley, Ellen Jo Baron, David A B Dance, Daniela Fusco, Caterina Fanello, Yukari C Manabe, Margaret Mokomane, Paul N Newton and 3 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Generating Actionable Data From Antimicrobial Resistance Surveillance: Insights From the Fleming Fund's International Experience.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 10 countries.

Peter J DaileyFoundation for Innovative New Diagnostics (FIND), Malaria and Fever Program, Chemine des Mines 9, Geneva 1202, Switzerland. Peter.Dailey@finddx.org.ORCID 0000-0002-5802-4115
Jennifer OsbornFoundation for Innovative New Diagnostics (FIND), Malaria and Fever Program, Chemine des Mines 9, Geneva 1202, Switzerland. jennifer.osborn@finddx.org.
Elizabeth A AshleyCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. liz@tropmedres.ac.ORCID 0000-0002-7620-4822
Ellen Jo BaronDepartment of Pathology, Stanford University, Palo Alto 94304, CA, USA. ejbaron@stanford.edu.
David A B DanceCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. david.d@tropmedres.ac.ORCID 0000-0002-7620-4822
Daniela FuscoPole of Clinical Research, French Institute of Health and Medical Research, Paris 75013, France. fusco@bnitm.de.
Caterina FanelloCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. Caterina@tropmedres.ac.
Yukari C ManabeDivision of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. ymanabe@jhmi.edu.
Margaret MokomaneNational Health Laboratory, Gaborone, Botswana. bafanamargaret@gmail.com.
Paul N NewtonCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. Paul.Newton@tropmedres.ac.
Belay TessemaDepartment of Medical Microbiology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. bt1488@yahoo.com.ORCID 0000-0003-1475-7357
Chris IsaacsFoundation for Innovative New Diagnostics (FIND), Malaria and Fever Program, Chemine des Mines 9, Geneva 1202, Switzerland. chris.isaacs@connected-dx.com.
Sabine DittrichFoundation for Innovative New Diagnostics (FIND), Malaria and Fever Program, Chemine des Mines 9, Geneva 1202, Switzerland. sabine.dittrich@finddx.org.
FIND · CHUniversity of London · GBBotswana Vaccine Institute (Botswana) · BWInserm · FRJohns Hopkins University · USStanford University · USUniversity of Gondar · ETUniversity of Kinshasa · CDUniversity of Oxford · GB

Funding

HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis.D43TW009771 · FIC · JOHNS HOPKINS UNIVERSITY · PI CASTELNUOVO, BARBARA, KAMBUGU, ANDREW DDUNGU · 2014 to 2023
$3.3M
FIC NIH HHS D43 TW009771UK goverment PDP funding DFID03Wellcome Trust
6 · The paper itself

Abstract

Bacterial blood stream infections (BSI) are a common cause of mortality and morbidity globally. As the causative agents and the resulting treatment decisions vary, near-patient testing and surveillance tools are necessary to monitor bacterial causes and resistance to antimicrobial agents. The gold standard to identify BSIs is blood culture (BC), a methodology not widely available in resource-limited settings. The aim of the study was to map out a target product profile of a simplified BC system (SBCS) to inform product development efforts. To identify the desired characteristics of a SBCS, we enlisted a small group of specialists working in Africa and Asia. Questions were used to understand challenges and how these constraints inform system requirements. The specialists were infectious disease physicians, public health/clinical microbiologists, clinical researchers, and technology experts with different geographical backgrounds. All suggested that BC should ideally be available at the district hospital level. Many of the same operational challenges, such as limited availability of culture bottles, electricity and internet connectivity, profuse dust, the lack of ambient temperature control, and human capacity constraints were identified across the different regions. BCs, although the accepted gold standard for diagnosis of BSIs, are not widely available outside of reference/research centers in Africa and Asia. To extend the reach of this important tool, it is crucial to engage product developers and academic research partners to develop accessible alternatives.

Indexed as

AMRblood culturehemocultureLMICslow- and middle-income countriesmicrobiologyresource limitedsepsistarget product profile

Identifiers

PMID30641976
PMCPMC6468589
OpenAlexW2910118544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.